chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bruise at the injection site; Left arm started hurting and aching again at injection site; Trouble sleeping last night; Blue blood clot on left hand/ Bump on hand; Sore left arm; Stomach occasionally jumps; Feeling "queasy" occasionally; A spontaneous report was received from a 80-year-old, female, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore left arm, feeling queasy, stomach occasionally jumps, a blue blood clot and a bump on hand, hurting and aching at injection site, bruise at the injection site, and trouble sleeping last night.  The patient's medical history included hypothyroidism. Products known to have been used by the patient, within two weeks prior to the events, included Levothyroxine sodium.  On 04 Mar 2021, prior to onset of events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 040A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 05 Mar 2021, one day post vaccination, the patient experienced sore left arm that eventually went away, felt queasy and her stomach occasionally jumped. On 06 Mar 2021, the patient noticed a blue blood clot on her left hand and stated that it was like a bump. On 10 Mar 2021 patient has seen the nurse for  bump on her hand and was told likely from strain on a tendon or blood vessel. she was told to ice the bump. On 15 Mar 2021, she had trouble sleeping. On 16 Mar 2021, she had hurting and aching at the site of injection and bruise at injection site.  Action taken with mRNA-1273 in response to events was not provided.  The outcome of the event, sore left arm was resolved on an unspecified date in Mar2021 and outcome of the events feeling queasy, stomach occasionally jumps, a blue blood clot, a bump on hand, hurting and aching at injection site, bruise at the injection site and trouble sleeping last night was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I got extremely lethargic and tired around 5pm but pushed through the day until about 9pm.  When I went to bed at that time, I could not move my arms and sat up to avoid vomiting.  I woke still feeling nauseous and had difficulty moving my arms.  Again, I pushed through the day, finally going to sleep at around 2pm.  I slept soundly.  The following 4 days I felt lethargic and "heavy" slowly re-gaining my capacities until fully recovered.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting  Narrative:
Pain at the injection site; Redness and warmth at the injection site; Swelling at the injection site; warmth at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd June 2022 11:00, the patient received the 1st dose of Shingrix. In June 2022, 24 hrs after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling and injection site warmth. The patient was treated with paracetamol (Tylenol) and non-drug therapy (Ice Pack (No Medication)). On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling and injection site warmth were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-JUN-2022 Reporter's Comment: The patient self-reported this case. The patient received dose of Shingrix vaccine into right arm at approximately 11 am and experienced pain, redness, swelling and warmth at the injection site approximately 24 hours later. The patient stated that all symptoms got gradually worked over the next few days.  The patient also stated that redness at injection site spread until it was wider than the width of their hand.  The patient was taking Tylenol and applying ice to the site to relieved symptoms.  The patient also stated that as soon as effects of Tylenol wore off and ice was removed, all symptoms were back at full intensity.  The events pain, swelling, and warmth resolved approximately two weeks after dose was received and redness resolved approximately three weeks after dose was received.  The reporter did not consent to follow-up.
pt recv vax & devel a welt @ the inj site;a 2 inch area of redness devel around the welt;the redness extended to involved the entire lt thigh;
Fever of up to 103.4 degrees Fahrenheit, headache, chills, extreme fatigue, full-body soreness. No treatment aside from rest, lots of fluids, and Ibuprofen for headache.
Pt received flumist inhalation on 12/13/2007. Pt c/o if facial tingling within 10 minutes of vaccination. Pt waited in vaccination area for approximately 20 minutes. She then left and returned 20 more minutes later c/o a fine rash on her left arm and face. Pt was instructed to have someone drive her to the clinic.
had received in last Saturday but after the Saturday I  have cold; in my left hip much pain; Cough; Yes I want to know what happened in my chin; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry Date was Unknown), via an unspecified route of administration on an unspecified date in May2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. On an unspecified date in May2021, the patient had received on last saturday but after the saturday patient had cold, in patient left hip much pain, cough and yes patient want to know what happened in chin. The outcome of the events was unknown.    Information about lot/batch number has been requested. No follow-up attempts are completed; Information about lot/batch number cannot be obtained.
Chills, severe muscle aches, fever that reached 102.3 F, headache, and diarrhea. Tylenol was taken at 12:30 am on Tuesday, again in the afternoon and again in the evening. The fever did not go down until late Tuesday night.
Starting 12/29/2021, I had to leave work because all of a sudden I got a headache, fever, dizzy, fatigued and felt like I had the flu. I was informed to leave. I got 3 PCR tests which came back negative. I had such severe fatigue and tiredness that even after 8-9 hours of sleep, taking a shower would drain me to the point where I'd have to sit down and rest. I went to the doctor because the symptoms were not getting better. They said that it could've been the flu but not sure, and that something in my body was triggered and has not calmed down. To this day, I still experience stamina and fatigue issues. Also, I have pain from head to toe in my joints and muscles. They have not figured out the root cause yet.
Fatigue; Nausea; Vomiting; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills). At the time of the report, FATIGUE (Fatigue), NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
1/20/21 had injection, told them about her health concerns which they consulted other people and they let her get the injection, she had to sit for 35 minutes due to history.  At about 8:00 PM her head started hurting bad, having fever and chills, body started aching all over which lasted to Friday 1/22/21, took Tylenol which helped.  Friday her headache was lingering, but not as severe, chills and fevers remained.  On Saturday, 1/23/21 could not breath, stayed around the house.  Her husband had to go to the Dr on 1/26/21 and was still having breathing problems, kept taking Tylenol.  After his APT she could not breath, went to UC, gave her a breathing treated, Albuterol and it seemed to make it worse.  Was wheezing a few weeks early and had scheduled her an APT for a pulmonologist which was on 1/27/21.  Went to the pulmonologist who felt it could have been stress related or if it was from the vaccination or not.   He prescribed her steroids and breathing treatments at home.  has FU in 2 weeks with him.  Still having difficulty breathing.
Approximately one minute or two after the injection, I began to feel light-headed. Soon after, I became unconscious, at which time I dropped items that I was holding in my hands and slumped out of my chair. I remained unconscious for a few minutes. During this time, I was informed that the pharmacist had called the EMS. I continued to feel light-headed, and I had some trouble breathing as my throat felt constricted. Then, I vomited a few minutes before the EMS arrived. The EMS checked if my vital signs had returned to normal.
neck and head ache, chills, nausea, lightheaded.  On 4/11/21 suffered a stroke.
About MN 19MAR92 onset of vomiting, cranky & c/o abdominal pain; t102.5 taken to ER by parents, put on clear liquid die;
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated intramuscularly with GARDASIL (lot # not reported).  Subsequently, the patient fainted.  The patient sought unspecified medical attention.  This is one of several reports received from the same source.  Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 70-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included shingles vaccine (old shingles vaccine received 2.5 to 3 years before the time of reporting). On 17th September 2018, the patient received SHINGRIX (intramuscular). In September 2018, 10 hrs after receiving SHINGRIX, the patient experienced allergic reaction, fever, nausea, diarrhea, loss of energy and gastrointestinal disorder. On 18th September 2018, the patient experienced injection site erythema and injection site rash. On 21st September 2018, the patient experienced rash. The patient was treated with Ice Pack (Nos), CORTIZONE 10 and BENADRYL Gel. In September 2018, the outcome of the fever, nausea, diarrhea, loss of energy and gastrointestinal disorder were recovered/resolved. On an unknown date, the outcome of the allergic reaction was unknown and the outcome of the injection site erythema, injection site rash and rash were not recovered/not resolved. It was unknown if the reporter considered the allergic reaction, fever, nausea, diarrhea, injection site erythema, injection site rash, rash, loss of energy and gastrointestinal disorder to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX at around 12:30 in the left arm. About 10 to12 hours later she developed a fever of 100.9 degree Fahrenheit. The patient's normal body temperature 97.6 degree Fahrenheit, she also experienced no energy, nausea, a bout of diarrhea and her digestive system felt weird at an unknown date. The next day of receiving the injection she experienced redness at the injection site the size of a softball. The redness went down to her elbow. The patient used the terms redness and rash at the injection site to describe the events. The patient said that at the time reporting the rash was growing in size. The patient had put ice packs, CORTIZONE 10+ and BENADRYL gel and it did not help. On the day of reporting, the patient woke up with a rash on her face, and she was taking BENADRYL around the clock to treat it. The patient said that her pharmacist documented everything as an allergic reaction in their system. In the morning of the reporting day, the patient was visiting a Nurse practitioner. The patient did not have an assigned physician. The patient provided contact details of nurse practitioner that she was visiting.
This spontaneous report as received from a physician via a company representative, refers to two female patients of unknown age. The concurrent conditions and medical history of the patients were not reported. On unknown dates, the patients were vaccinated with the first dose of ZOSTAVAX (strength, dose, route of administration, anatomical location, lot number and expiration date were unknown) for prevention of shingles (prophylaxis). There were no concomitant therapies reported. The reporter stated that, on an unknown date after receiving ZOSTAVAX, the patients developed shingles. No product quality complaint was involved. The outcome of herpes zoster was unknown. The causality between ZOSTAVAX and the event was not provided. Additional information has been requested.
While sitting in class, suddenly passed out and vomited at the same time. Came to about 30 seconds later. No additional adverse affects after the episode.
patient stated feeling dizzy and seeing darks spots. patient passed out for about 30 seconds.
Pt reported headache and sever chills starting the night after receiving the shot. Chills were bad enough that he was not able to get out of bed. Chills subsided in the morning. Headache persisted until afternoon.
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date in 2007, the patient was vaccinated with a dose of ZOSTAVAX, (dose, route of administration, anatomical location, lot # and expiration date were not reported) for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster (onset date was not provided). On or about 25-AUG-2016, the patient was treated for a persistent vesicular outbreak accompanied by weakened immune symptoms, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The reporter determined the events to be related to the ZOSTAVAX.
This spontaneous report as received from a pharmacist refers to a 59 or 60 year old female patient. The patient's medical history and drug reactions were not provided. The pharmacist reported that the patient who received a dose of ZOSTAVAX (lot#, dose, route unknown) on 12-MAY-2014, developed a rash on her torso and back, and was diagnosed with shingles by an unspecified physician via an office visit. Outcome of the event was reported as not recovered and reporter's causality of therapy to the event was unknown. Additional information has been requested.
Patient on 7th, got vaccination and covid test (negative).  first few days after vaccination, had asthma like symptoms. o2 sat was greater than 97% all the time. felt little tight.  10 days after vaccination, started rashes on both hands. took 50mg of Benadryl at night time.  next day, rashes went up to right elbow. not so many but following nerve lines. both hands mostly out side. 1 each on my left inner 3rd / 4th finger. 3 rashes on 4th inner right finger.  took 25mg of Benadryl at night time.  3rd day, rashes developed on my left elbow as well. Went to ER per advice.  got Decadron IM shot, Benadryl,  and Pepcid.  Took chest x ray; clear.  prescribed of prednisone 40mg po daily  for 4 days.  4th day, no new rashes. still have rashes.
approx 9hr p/vax pt devel redness & warmth from the inj site to the elbow;pt seen by MD who dx cellulitis & prescribed duricef;pt recovered;
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unspecified dates since 05-JAN-2017, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot number M034780, expiration date 15-APR-2019 and lot number M005714, expiration date 03-OCT-2017 (dose and route of administration were not provided) for prophylaxis. The reporter had not been informed of any adverse effects. Administered doses of GARDASIL 9 were exposed to a temperature excursion between 32°F and 36°F (34°F) for 3 hours and 3 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA004300: US-009507513-1702USA010195.
headache, scratchy throat, cough w/ occas short of breath and dizziness started on 12/24/21, the day after receiving the Moderna booster. Visit to walk-in clinic on 12/30/21 due to continued symptoms and feeling unwell. Dr. exam was positive for nasal mucosa edema and rhinorrhea. Prednisone ordered for 5 days for viral upper respiratory infection. Saline nasal rinses also suggested by provider and were performed once to twice a day. Today I still continue to have headaches and cough, but cough is decreasing.
Episodes (seizure-like appearance), left arm and leg muscle tension/contraction (clutching of hand, raising of leg), leftward face contortion, extreme pain along entire left side. Periodicity: many events some days (at least 11 events on one day), some days (even a few in a row) no events.  Examination for stroke and heart attack were negative. Initial diagnosis of faciobrachial dystonia, followed by negative laboratory blood-test confirmation of diagnosis. No current diagnosis. Several rounds of treatment by IV steroid and oral steroid.
Pt verbalized his fear and anxiety about getting infection. He was lying down while getting Hep A, left deltoid IM and Tdap right deltoid IM. After receiving shots, pt sates not feeling well states "I am seeing spots". Transferred to RN and doctor.  Vital signs normal, pulse OK 100s%. Pt lying flat on stretcher but started to hyperventilate with arms and legs flaning. No serious, EKG normal.  Transported to ER where Atavan was given diagnosed with panic attacks.
Severe diarrhea. Contacted PC at 8:00am.  Advised to begin Imodium, and adult pedialyte and follow. BRAT    If it got worse contact urgent care.   Projectile vomiting  twice at 10:30 pm. None of the written information mentioned diarrhea as a side effect!
Pt. was given MMR at 12 month well child visit on 5/3/04. Mother reports fever 5 days  post-vaccination and a rash on 5/16/04.  Rash was non-puritic in nature over pt's. entire body.  Lesions were 0.2 cm to 1 cm diameter, macular, and erythematous.  Pt. given Des Owen lotion 0.05% to apply bid for 7 days.  Mother informed this treatment is not necessary, but may help if rash is related to a different cause.
Dizziness, feeling heavy. Vitals stable. Given water, crackers, juice.
administered Moderna Covid 19 Bivalent after 30 day use by date; No Adverse Event; administered Moderna Covid 19 Bivalent after 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid 19 Bivalent after 30 day use by date), PRODUCT STORAGE ERROR (administered Moderna Covid 19 Bivalent after 30 day use by date) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 013H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid 19 Bivalent after 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (administered Moderna Covid 19 Bivalent after 30 day use by date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid 19 Bivalent after 30 day use by date), PRODUCT STORAGE ERROR (administered Moderna Covid 19 Bivalent after 30 day use by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid 19 Bivalent after 30 day use by date) and PRODUCT STORAGE ERROR (administered Moderna Covid 19 Bivalent after 30 day use by date).    No concomitant medication information provided.  It was reported that HCP had called to inform that 4 or 5 adult patients were accidentally administered Moderna COVID-19 Bivalent after 30 day use by date.  No treatment information provided.   This case was linked to MOD-2022-687538, MOD-2022-687539, MOD-2022-687540, MOD-2022-687454, MOD-2022-687542 (Linked Report).; Sender's Comments:  MOD-2022-687454:Original Case : MOD-2022-687454 MOD-2022-687540:Original Case : MOD-2022-687454 MOD-2022-687539:Original Case : MOD-2022-687454 MOD-2022-687542:Original Case : MOD-2022-687454 MOD-2022-687538:Original Case : MOD-2022-687454
Hypertensive Emergency Blood pressure 216/91 with 5 minutes of administration and remained elevated for hours
feeling weak; could not get out of bed for day and a half; feeling tired; sweating profusely in the middle of the night; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating profusely in the middle of the night), FATIGUE (feeling tired), ASTHENIA (feeling weak) and MALAISE (could not get out of bed for day and a half) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for an unknown indication.     The patient's past medical history included No adverse event.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced HYPERHIDROSIS (sweating profusely in the middle of the night). On an unknown date, the patient experienced FATIGUE (feeling tired), ASTHENIA (feeling weak) and MALAISE (could not get out of bed for day and a half). At the time of the report, HYPERHIDROSIS (sweating profusely in the middle of the night), FATIGUE (feeling tired) and MALAISE (could not get out of bed for day and a half) outcome was unknown and ASTHENIA (feeling weak) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication provided. No treatment drugs were provided.    Reporter did not allow further contact